CoChat

Notch1 loss of heterozygosity causes vascular tumors and lethal hemorrhage in mice

Open access

The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.

Abstract

The role of the Notch signaling pathway in tumor development is complex, with Notch1 functioning either as an oncogene or as a tumor suppressor in a context-dependent manner. To further define the role of Notch1 in tumor development, we systematically surveyed for tumor suppressor activity of Notch1 in vivo. We combined the previously described Notch1 intramembrane proteolysis-Cre (Nip1::Cre) allele with a floxed Notch1 allele to create a mouse model for sporadic, low-frequency loss of Notch1 heterozygosity. Through this approach, we determined the cell types most affected by Notch1 loss. We report that the loss of Notch1 caused widespread vascular tumors and organism lethality secondary to massive hemorrhage. These findings reflected a cell-autonomous role for Notch1 in suppressing neoplasia in the vascular system and provide a model by which to explore the mechanism of neoplastic transformation of endothelial cells. Importantly, these results raise concerns regarding the safety of chronic application of drugs targeting the Notch pathway, specifically those targeting Notch1, because of mechanism-based toxicity in the endothelium. Our strategy also can be broadly applied to induce sporadic in vivo loss of heterozygosity of any conditional alleles in progenitors that experience Notch1 activation.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1172/jci43114

Cites

45 of 45 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

  • Generalized lacZ expression with the ROSA26 Cre reporter strain

    Soriano, P. (1999) · Nature Genetics · doi:10.1038/5007 · Cited by 4,859 · cited 6×

    “We have previously reported that when N1::Cre is combined with the RosaLacZ reporter, the excision of the floxed stop cassette by ligand-dependent release of Cre indelibly labels cells that have experienced Notch1 activation.”
    BackgroundInfluential
  • The Canonical Notch Signaling Pathway: Unfolding the Activation Mechanism

    Kopan, R., & Ilagan, M. X. G. (2009) · Cell · doi:10.1016/j.cell.2009.03.045 · Cited by 3,643 · cited 1×

    “Introduction The Notch pathway is an evolutionarily conserved signaling mechanism that plays essential roles both during development and in the maintenance of adult tissue homeostasis in metazoan (1).”
    BackgroundSelf-citation
  • Cre reporter strains produced by targeted insertion of EYFP and ECFP into the ROSA26 locus

    Srinivas, S., Watanabe, T., Lin, C.-S., William, C. M., Tanabe, Y., Jessell, T. M., & Costantini, F. (2001) · BMC Developmental Biology · doi:10.1186/1471-213x-1-4 · Cited by 3,121 · cited 8×

    “CD105+CD45– proliferating liver ECs from N1::Crelo/flRosaEYFP/LacZ and N1::Crelo/+RosaEYFP/LacZ mice were collected (Figure 6A), and the DNA was purified and subjected to PCR amplification in order to detect the 3 Notch1 alleles: a normal promoter in the N1::Crelo allele, a floxed promoter in N1fl allele, and a rearra…”
    BackgroundInfluential
  • Activating Mutations of NOTCH1 in Human T Cell Acute Lymphoblastic Leukemia

    Weng, A. P., Ferrando, A. A., Lee, W., Morris, J. P., Silverman, L. B., Sanchez-Irizarry, C., Blacklow, S. C., Look, A. T., & Aster, J. C. (2004) · Science · doi:10.1126/science.1102160 · Cited by 2,715 · cited 2×

    “Jeannet R, et al. Oncogenic activation of the Notch1 gene by deletion of its promoter in Ikaros-deficient T-ALL [published online ahead of print September 9, 2010].”
    Background
  • Notch/γ-secretase inhibition turns proliferative cells in intestinal crypts and adenomas into goblet cells

    van Es, J. H., van Gijn, M. E., Riccio, O., van den Born, M., Vooijs, M., Begthel, H., Cozijnsen, M., Robine, S., Winton, D. J., Radtke, F., et al. (2005) · Nature · doi:10.1038/nature03659 · Cited by 1,543 · cited 1×

    “Considering that Notch1 is continuously required in multiple tissues during development and in the adult (33), especially in the gut (7, 34) and mammary gland (35) stem cell populations, a NIP::Cre allele coupled with floxed alleles of tumor suppressors offers a better model to mimic LOH disease development in human p…”
    Background
  • Notch signaling is essential for vascular morphogenesis in mice

    Krebs, L. T., Xue, Y., Norton, C. R., Shutter, J. R., Maguire, M., Sundberg, J. P., Gallahan, D., Closson, V., Kitajewski, J., Callahan, R., et al. (2000) · Genes & Development · doi:10.1101/gad.14.11.1343 · Cited by 1,060 · cited 1×

    “Concomitant loss of signals from other Notch receptors, such as Notch4 in ECs (38) and Notch2/3 in pericytes (39–41), may have accelerated the tumor formation in their model (37).”
    Background
  • Blockade of Dll4 inhibits tumour growth by promoting non-productive angiogenesis

    Noguera-Troise, I., Daly, C., Papadopoulos, N. J., Coetzee, S., Boland, P., Gale, N. W., Chieh Lin, H., Yancopoulos, G. D., & Thurston, G. (2006) · Nature · doi:10.1038/nature05355 · Cited by 1,032 · cited 4×

    “The Notch pathway has emerged as a target to block angiogenesis in solid tumors (9, 10, 36) and eliminate tumor-initiating cells (13), either by the administration of anti-Dll4 antibody Figure 5 Characterization of vascular tumor cells.”
    BackgroundResultInfluential
  • Inhibition of Dll4 signalling inhibits tumour growth by deregulating angiogenesis

    Ridgway, J., Zhang, G., Wu, Y., Stawicki, S., Liang, W.-C., Chanthery, Y., Kowalski, J., Watts, R. J., Callahan, C., Kasman, I., et al. (2006) · Nature · doi:10.1038/nature05313 · Cited by 986 · cited 4×

    “The Notch pathway has emerged as a target to block angiogenesis in solid tumors (9, 10, 36) and eliminate tumor-initiating cells (13), either by the administration of anti-Dll4 antibody Figure 5 Characterization of vascular tumor cells.”
    BackgroundResultInfluential
  • Notch1 functions as a tumor suppressor in mouse skin

    Nicolas, M., Wolfer, A., Raj, K., Kummer, J. A., Mill, P., van Noort, M., Hui, C.-C., Clevers, H., Dotto, G. P., & Radtke, F. (2003) · Nature Genetics · doi:10.1038/ng1099 · Cited by 971 · cited 1×

    “In contrast to gain-offunction mutations in Notch1 and their oncogenic role in T-ALL (3, 4), and perhaps in solid tumors, Notch1 loss-of-function mutations have only been implicated in a limited number of tumors, such as skin (2), where Notch1 loss promotes tumor formation non–cell-autonomously by creating a wound-lik…”
    Background
  • Notch1 is required for the coordinate segmentation of somites

    Conlon, R. A., Reaume, A. G., & Rossant, J. (1995) · Development · doi:10.1242/dev.121.5.1533 · Cited by 852

Show all 45 references

Cited by

Items 101–121 of 121

Metadata

Authors
Liu, Z., Turkoz, A., Jackson, E. N., Corbo, J. C., Engelbach, J. A., Garbow, J. R., Piwnica-Worms, D. R., & Kopan, R.
Affiliations
Washington University in St. Louis (US)
Corresponding author
Kopan, Raphael
Venue
Journal of Clinical Investigation
Published
2011-02-01
Volume
121
Issue
2
Pages
800-808
ISSN
0021-9738 (ISSN-L)
OpenAlex
W2145967409
Cited by
119
References
45
Citations by year
2026: 4 · 2025: 2 · 2024: 2 · 2023: 1 · 2022: 4 · 2021: 2 · 2020: 4 · 2019: 2 · 2018: 8 · 2017: 8 · 2016: 6 · 2015: 12 · 2014: 15 · 2013: 18 · 2012: 10
FWCI
8.32
Type
journal article
Language
en
Open access
Locations
  • Journal of Clinical Investigation (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • Digital Commons@Becker (Washington University School of Medicine) (submittedVersion)
Funders
  • Alvin J. Siteman Cancer Center
  • National Institutes of Health
  • National Eye Institute (R01EY018826)
  • National Cancer Institute (P30 CA 91842, U24CA083060, U24 CA83060, P50CA094056, P30CA091842)
  • National Institute of Diabetes and Digestive and Kidney Diseases (R01DK066408)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Developmental Biology and Gene Regulation
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
  • Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
Keywords
Notch1, loss of heterozygosity, tumor suppressor function, vascular tumors, hemorrhage, Notch signaling, conditional alleles, drug safety, mouse model
MeSH terms
Animals, Hemorrhage, Humans, Magnetic Resonance Imaging, Recombinant Fusion Proteins, Signal Transduction, Survival Rate, Disease Progression, Vascular Neoplasms, Loss of Heterozygosity, Mice, Receptor, Notch1

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.